JKN-2304

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameJKN-2304
Drug Alias NameJKN2304JKN-2304
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonistsMuscarinic acetylcholine receptor M3 antagonists
TargetsBeta-2 adrenergic receptorMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJoincare Pharmaceutical Group Industry Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAnhui Shuobai Pharmaceutical Co LtdBeijing Shuobai Pharmaceutical Technology Co LtdJoincare Pharmaceutical Group Industry Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A